Seven days after peripheral inoculation with an avirulent strain of Semliki Forest virus, the brains of CBA and nude mice exhibited a mononuclear inflammation and spongiform degeneration. Mice that had received cyclophosphamide (150 mg/kg) 24 h after infection showed no pathology until day 11. However, immunofluorescence studies of the brains of immunosuppressed, infected mice demonstrated viral antigen within the soma and processes of neurons at earlier periods. The brain lesions could be reconstituted on day 7 in immunosuppressed, infected recipients with 6-day immune spleen cells. Immune Semliki Forest virus (SFV) is an alphavirus that produces a central nervous system (CNS) infection in experimental animals. Unlike some virulent strains of SFV which produce a fatal encephalitis in adult mice, the A7 strain and its derivatives replicate in the brain for a limited period without causing clinical signs or death (5). Even though there is a subclinical infection, the brains exhibit an inflammatory spongiform degeneration. Previous studies using an immunosuppressive agent suggest that the brain lesions are immunopathological (27).
Seven days after peripheral inoculation with an avirulent strain of Semliki Forest virus, the brains of CBA and nude mice exhibited a mononuclear inflammation and spongiform degeneration. Mice that had received cyclophosphamide (150 mg/kg) 24 h after infection showed no pathology until day 11. However, immunofluorescence studies of the brains of immunosuppressed, infected mice demonstrated viral antigen within the soma and processes of neurons at earlier periods. The brain lesions could be reconstituted on day 7 in immunosuppressed, infected recipients with 6-day immune spleen cells. Immune spleen cells depleted of T lymphocytes, the non-immunoglobulin-bearing population deficient in B lymphocytes, or immune sera plus nonimmune bone marrow cells could also reconstitute the lesions. However, inflammation and spongiform changes were reduced when donor immune cells were depleted of either T or B lymphocytes. When both T and B lymphocytes were removed from the donor immune population, recipient brains did not show pathology. The results demonstrate that either antibody or immune T cells can trigger pathology, but there is also participation of nonimmune bone marrow-derived mononuclear cells, probably of the monocyte-macrophage lineage.
Immune responses can play a dual role in viral pathogenesis. One function is to reduce viral titers in tissue and thus decrease viral cytolytic activity. However, these same virus-specific responses can also have deleterious effects on tissue. The immune-mediated damage may be so extensive as to dominate the pathological expression of the infectious process. This is illustrated in several experimental virus infections of rodents, including lymphocytic choriomeningitis virus (14) , parainfluenza type 1 virus (15) , and Theiler's murine encephalomyelitis virus (20) . Postinfectious encephalomyelitis, acute hemorrhagic leukoencephalitis, and LandryGuillain-Barre syndrome are examples of human disorders where immune-mediated damage to the nervous system may occur subsequent to a viral infection (1, 25) .
Semliki Forest virus (SFV) is an alphavirus that produces a central nervous system (CNS) infection in experimental animals. Unlike some virulent strains of SFV which produce a fatal encephalitis in adult mice, the A7 strain and its derivatives replicate in the brain for a limited period without causing clinical signs or death (5) . Even though there is a subclinical infection, the brains exhibit an inflammatory spongiform degeneration. Previous studies using an immunosuppressive agent suggest that the brain lesions are immunopathological (27) .
There are several possible immunological mechanisms of tissue injury which include: immediate hypersensitivity; direct lysis of cells by antibody and complement; the recruitment of inflammatory cells by antigen-antibody complexes; the direct lysis of cells by T lymphocytes; the recruitment of inflammatory cells by T lymphocytes; and the antibody-dependent cellular cytotoxicity reaction whereby cell lysis occurs through the specific interaction between target cell-bound antibody and K cells. To define the specific mechanisms involved in SFV encephalitis, passive transfer experiments were performed. The results show that both humoral and cellular immune mechanisms are involved in the full expression of the pathological process.
MATERIALS AND METHODS Animals. Female CBA/H mice were used at 4 to 6 weeks of age. Nude mice (nu/nu) were derived from (BALB/c x CBA)F, hybrids and were used at 6 to 7 weeks of age. All strains were bred at the Animal Breeding Establishment of the John Curtin School of Medical Research.
Virus. 7 . Control groups always included mice which received SFV on day 0 and cyclophosphamide on day 1. Adoptive transfers using other experimental designs are described in their appropriate sections.
Anti-SFV serum. CBA/H mice were given three i.p. injections of 106 PFU of SFV. The second injection was given 2 weeks after the first, and the third injection was given 1 week later. All animals were bled 7 days after the last injection; the sera were pooled, heat inactivated at 56°C for 30 min, and stored in portions at -20°C. In repeated assays, the SFV neutralization titer was 1:2,560.
Cyclophosphamide. Cyclophosphamide (Endoxan-Asta), obtained from Bristol Laboratories, Crows Nest, N.S.W., Australia, was given to mice i.p. at a dose of 150 mg per kg of body weight.
Sampling techniques. Mice were anesthetized with chloroform and exsanguinated. The sera were collected, heat inactivated at 56°C for 30 min, and stored at -20°C for antibody determination. The brain was then removed and cut midsagittally. One half of the brain was stored at -70°C for virus assay; the other half was fixed in 10% formalin saline for histological examination.
Hemagglutination-inhibiting (HI) antibody titration. The Takatsy microtechnique (26) was adapted to the general methods of Clarke and Casals (9) . SFV hemagglutinins were prepared by sucroseacetone extraction of infected infant mouse brain. Pooled sera were extracted with acetone-ether and absorbed with gander erythrocytes before testing for HI antibodies. Endpoints were taken at the level of 100% agglutination.
Histology. Brains were embedded in paraffin, sectioned sagittally at four levels, and stained with hematoxylin and eosin. The slides were coded and examined in a blind fashion. 21, 28 , and 35 postinfection, four mice from each group were sacrificed; the brains were removed and cut midsagittally. One half of the brain was used for viral titration, and the other was used for histopathology. For nude mice, the study was carried out to only 9 days poesinfection.
No clinical signs or mortality were noted in any mouse throughout the study. In all three groups the brain virus titers rose rapidly within 24 h postinfection, reaching higher maximal titers in the nude and cyclophosphamide-treated mice than in normal mice (Fig. 1) . In both normal and nude mice, viral titers began to decline on day 5. In normal mice, they fell to undetectable levels by day 7. However, virus titers in nude mice tapered off on day 7 without complete clearing by day 9. Viral clearance was delayed in the cyclophosphamide-treated group until day 11, falling to undetectable levels by day 15.
Pathology in the infected normal mice was first noted on day 5 postinfection and was characterized by a mononuclear perivascular inflammation as well as focal accumulations of mononuclear cells within the brain parenchyma. By 7 days postinfection, cystic lesions appeared within the brain in association with mononuclear inflammatory cells and reactive astrocytes ( Fig.  2A) . These lesions, representing a spongiform degeneration, were associated with minimal neuronal degeneration and could be found throughout the brain, although they occurred most frequently in the brain stem and cerebellum (Fig.  2B, C) . The cystic areas in the white matter were at times confluent, appearing as large foci (Fig. 2D) . The inflammatory spongiform degen-
eration was maximal between 7 and 21 days postinfection and had resolved over the ensuing 2 weeks.
The initial changes in the brains of infected nude mice were found on day 5 with focal accumulations of mononuclear inflammatory cells, followed on day 7 by an inflammatory spongiform degeneration (Fig. 3) . However, the intensity of the perivascular cuffing, focal mononuclear infiltrates, and associated spongiform changes were less prominent than lesions in normal, infected mice. Inflammation did not appear in the brains of cyclophosphamide-treated, infected mice until day 9, with spongiform lesions developing by day 11. When the lesions appeared in these mice, the inflammation and cystic changes were more intense than in normal or nude mice.
Immunofluorescent study of the brains of normal and immunosuppressed mice after primary infection with SFV. One group of CBA mice received an i.p. inoculation of 1060 PFU of SFV. A second group was given an i.p.
inoculation of 1060 PFU of SFV followed 24 h later by a single i.p. dose of cyclophosphamide (150 mg/kg). Two mice were sacrificed on days 1, 3, 5, and 7 postinfection. The brains were removed and cut midsagittally; one half of each brain was frozen in liquid N2 for immunofluorescent study, and the other half was fixed in formalin for histopathology.
The normal, infected mice failed to exhibit viral antigens in their brains at any time throughout the study. However, pathology was present which was identical both in temporal sequence and in appearance to that described previously. Fluorescent foci were first seen in the brains of immunosuppressed, infected mice beginning on day 5. The foci consisted of small groups of neurons which could be found within the cerebral hemispheres, brain stem, and Purkinje layer of the cerebellum. Viral antigen was not limited to the cytoplasm of infected cells but could be demonstrated on the dendrites and myelinated axons as well (Fig. 4) . Fluorescence was never observed in the meninges, choroid plexus, ependyma, or glial cells. The pattern of fluorescence on day 7 was similar to that on day 5, with only small groups of neurons and their processes exhibiting viral antigen. Pathology was absent in the brains of the immunosuppressed, infected mice throughout the 7 days of observation.
In the previous section, it was found that brain virus titers reached a higher maximum in cyclophosphamide-treated mice than in normals. In some arbovirus encephalitides, it has been shown that the amount of viral antigen in the brain is directly proportional to the virus titer (8, 10 'Significantly less than control group receiving virus plus cyclophosphamide (P < 0.001). (Table 3) . However, the inflammation and cystic changes were greater in the recipients of NMStreated immune cells and infected, normal controls. Both recipient groups also had reduced brain virus titers, although the antiviral activity was greater in the donor immune cell population that contained T lymphocytes. Serum antiviral antibody titers were lower in recipients that had received immune cells depleted of T lymphocytes. This finding could be attributed to a reduction in helper T-lymphocyte activity in the donor cell population (7) .
Effect of Ig-and Ig' immune cells on the pathological process. Immune mouse spleen populations were separated into Ig' cells and Igcells. The Ig" cell population consists mainly of B lymphocytes, whereas the Ig-population is comprised of T lymphocytes, macrophages, polymorphs, and stem cells (22 (Fig. 1) (18) . However, the early synthesis of IgM is unimpaired and is maximal on day 7 after SFV infection (6) . Thus, an antibodymediated process independent of T cells did produce pathology. This is further supported by the reconstitution of lesions in immunosuppressed, infected mice with immune cells deficient in T lymphocytes. Adoptive transfers with either the Ig' immune fraction (an enriched population of B lymphocytes) or antibody alone were unsuccessful. When normal BM cells were injected along with antibody, mononuclear inflammation with associated spongiform degeneration appeared in recipient brains. The mononuclear cells or their precursors must reside in the spleen and bone marrow as well as in nude mice. These cells are most likely to be of the monocyte-macrophage lineage. They can be recruited into infected tissue through the formation of antibody-antigen complexes and activation of the complement pathway. Ectromelia and chronic lymphocytic choriomeningitis virus infections in mice are examples where antibody, independent of T cells, can induce mononuclear inflammatory lesions which are histologically similar to T-cell-mediated lesions (4, 21) . Another possibility is that some of the mononuclear infiltrate is K cells. An antibody-dependent cellular cytotoxicity reaction is more commonly mediated by IgG binding to the target cells (23) . The findings discussed here suggest that humoral and cellular immune responses can independently produce qualitatively similar brain lesions during the course of SFV infection, probably through the recruitment of a common effector cell (monocyte-macrophage) into infected brain. Monocyte recruitment is immunologically mediated because adoptive transfer with spleen cells depleted of both T and B lymphocytes did not reconstitute lesions. If monocytes became activated macrophages within infected brain, they could produce spongiform necrosis by direct lysis of infected cells or indirectly through the release of hydrolytic enzymes (11, 12) . There remains the possibility that other cells, such as K cells or cytotoxic T lymphocytes, could act as effector cells in the immunopathogenesis.
The findings presented here are not unique. For example, in studies on experimental autoimmune thyroiditis, adoptive transfer and H-2 restriction of thyroid damage have demonstrated that either T lymphocytes or antibody can induce lesions (2, 28) . Similarly, the present study has demonstrated that both humoral and cellular immunological mechanisms may play a role in the evolution of CNS pathology that occurs during the course of avirulent SFV infection in mice.
